This test analyzes genes associated with different types of cancer, detecting higher numbers of patients who are likely to suffer from cancer, compared to panels with a selection of genes targeting a single type of cancer.
The MycancerRisk genetic test will analyze 40 genes related to the most common types of hereditary cancer.
These genes have been selected based on criteria defined by expert groups, evidence in gene-disease association and inclusion in the patient’s clinical management Guidelines.
A specialist consultation will be provided to the patient to assess the results and its implications
It analyzes the risk associated with the most common hereditary cancers
It provides relevant information to best match and guide the patient’s clinical management.
This type of information can also be helpful to first-degree relatives.
A team of experts performs variant interpretation based on state-of-the-art research.
All that is needed is a sample of your saliva or venous blood.
in only takes 15 minutes
UNI EN ISO ISO 9001:2008
UNI CEI EN ISO/IEC 17025:2005
Ring Test
CE-IVD devices
ReGenera Research Group Award
CSPro Illumina
LIMS
European Society of Human Genetics
Toscana Life Sciences
Incubatore Universitario Fiorentino
Via Madonna del Piano, 6
50019 Sesto Fiorentino (FI)
Cittadella di Doccia
Via delle Robinie, 22
50019 Sesto Fiorentino (FI)
(+39) 055 709 8483
(+39) 353 446 9286
Sezione chimica
Largo Torricelli, 7
52041 Pieve al Toppo (AR)
(+39) 055 031 7492
Personal Next is a project of Next Genomics Srl © 2021 P.IVA / C.F. 02140520970.
Website created by Oltremira — Value Project Agency.